Samcheondang Pharmaceutical (000250) is attempting a rebound on the 22nd, turning upward in early trading and overcoming the shock of the previous day's sharp decline.

As of 9:06 a.m. on the 22nd, Samcheondang Pharmaceutical's stock price is trading at 169,800 won, up more than 1% from the previous trading day. This is in stark contrast to the previous day, when it was pushed down to the lower limit during trading amid a surge in selling pressure.

Samcheondang Pharmaceutical, which started off strong in early trading the previous day, subsequently experienced an abrupt expansion of selling pressure, falling to the daily price limit and recording significant volatility. The investment sentiment that had been dampened in a single day is showing signs of revival today, driven by an inflow of bargain-hunting buyers.

The broader domestic stock market is also showing strength. At the same time, the KOSPI recovered the 7,100 level with gains of more than 5%, while the KOSDAQ also rose over 4%, reflecting an improving risk appetite among investors. Attention is also focused on the potential impact on the domestic market after major U.S. indices closed higher overnight, buoyed by the strength of semiconductor stocks including Nvidia.

However, some analysts note that it is still early in the session and Samcheondang Pharmaceutical's gain is modest, meaning further observation is needed to determine whether investor sentiment can stabilize following yesterday's extreme volatility and whether the rebound trend can be sustained into the afternoon session.

[This article is not intended to solicit investment. The final judgment and responsibility for all investments lie with the investor.]